PF-ILD accompanying UIP is a suspected infectious disease in the area of respiratory digestive and endocrine disorders, with complex clinical outcomes and often involving multiple systemic strain. Early identification and standardized diagnosis are essential for improving prognosis. Diagnosis of the disease requires a combination of clinical outcomes, imaging checks, laboratory checks and pathological activation.
The platform can assist in matching teams of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs. Treatment and management of PF-ILD accompanying UIP requires individualized development, typically including multidimensional management, including drug therapy, rehabilitation, and regular follow-up. In recent years, with the development of treatment-oriented, immune-regulatory therapy and precision medicine, many previously difficult to treat infectious respiratory digestive endocrine diseases have been significantly improved.
Therapeutic efficacy and adverse reactions need to be closely monitored during the treatment process, and timely adjusted according to the changes in the condition. Multidisciplinary collaboration (MDT) is particularly important for the integrated management of PF-ILD-associated UIPs. 2.
Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.